Download PDF
CC BY-NC-ND 4.0 · Avicenna J Med 2011; 01(01): 8-11
DOI: 10.4103/2231-0770.83717
ORIGINAL ARTICLE

Antibiotic utilization pattern in a general medical ward of a tertiary medical center in Saudi Arabia

A Al Shimemeri
Intensive Care Department, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
,
H Al Ghadeer
College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
,
Z Memish
Department of Health for Preventive Medicine, Ministry of Health, Riyadh, Saudi Arabia
› Author Affiliations
› Further Information
  PDF Download Permissions and Reprints

Abstract

To assess the pattern of antibiotic utilization and outcome of patients with bacteremia in a General Medical Ward, all positive blood cultures (BC) over a 12-month period from January 1994 to December 1995 were retrospectively reviewed. Fifty-two positive BC were recorded in 43 patients (63% males, 37% females; mean age 65.9 ± 16.6). 72% of the patients received antibiotics before or soon after obtaining the BC, and ceftriaxone was the most frequently-prescribed antibiotic (41.93%), either alone or in combination with other antibiotics. The bacteremia was due to gram-positive cocci in 60.46% of cases, gram-negative rods in 30.23%, and gram-positive rods in 9.30%. Positive BC due to contamination were not included. The most common gram-positive cocci were Staphylococcus epidermidis, followed by S. aureus, while the most common gram-negative bacilli were Brucella species, Proteus mirabilis, and Klebsiella sp. The suspected sources of the bacteremia were respiratory (21.2%), urinary (19.2%), or skin (19.2%). A subsequent change in the antibiotics regimen was done in 69.76% cases after BC results became available with no apparent effect on the outcome. Adding vancomycin and clindamycin was the most frequent change done (19.4% for each equally). Complications developed in 69.76% of patients, with 88.66% of them suffering from sepsis/shock. 69.23% of the patients improved and 30.77% expired; death was related to infection in 87.5% of cases. In conclusion, most bacteremia in the medical ward of the hospital were due to gram-positive cocci, which should be considered in antibiotic selection prior to BC. Risk factors for acquiring Brucellosis should always be obtained.

Keywords

Antibiotic - medical - Riyadh - Saudi Arabia - utilization


Publication History

Article published online:
09 August 2021

© 2011. Syrian American Medical Society. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Guglielmo BJ. Antimicrobial therapy. Cost-benefit considerations. Drugs 1989;38:473-80.
  • 2 Farrar WE. Antibiotics resistance in developing countries. J Infect Dis 1985;152:1103-6.
  • 3 Hogerzeil HV. Promoting rational prescribing: An international perspective. Br J Clin Pharmacol 1995;39:1-6.
  • 4 Marr JJ, Moffet HL, Kunin CM. Guidelines for improving the use of antimicrobial agents in hospitals: A statement by the Infectious Diseases Society of America. J Infect Dis 1988;157:869-76.
  • 5 Tenney JH. Controlled evaluation of the volume of blood cultured in detection of bacteremia and fungemia. J Clin Microbiol 1982;15:555-61.
  • 6 Kristinsson KG, Monnet DL. Increasing multidrug resistance and limited treatment options: Situation and initiatives in Europe. Euro Surveill 2008;13.pii:19043.
  • 7 Boucher HW, Talbot GH, Bradley JS, Edwards JE Jr, Gilbert D, Rice LB, et al. Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009;48:1-12.
  • 8 Esposito S, Leone S. Antimicrobial treatment for intensive care unit (ICU) infections including the role of the infectious disease specialist. Int J Antimicrob Agents 2007;29:494-500.
  • 9 Lepape A, Monnet DL, on behalf of participating members of the European Society of Intensive Care Medicine (ESICM). Experience of European intensive care physicians with infections due to antimicrobial-resistant bacteria. Euro Surveill 2009;14.pii:19393.
  • 10 Hanberger H, Monnet DL, Nilsson LE. Intensive care unit. In: Gould IM, van der Meer JW, editors. Antibiotic Policy - Theory and Practice. New York: Kluwer; 2005. p. 261-79.
  • 11 Borg MA, Zarb P, Scicluna EA, Rassian O, Gür D, Redjeb SB, et al. Antibiotic consumption as a driver for resistance in Staphylococcus aureus and Escherichia coli within a developing region. Am J Infect Control 2010;38:212-6.
  • 12 Meyer E, Schwab F, Pollitt A, Bettolo B, Schroeren-Boersch B, Trautmann M. Impact of a change in antibiotic prophylaxis on total antibiotic use in a surgical intensive care unit. Infection 2010;38:19-24.
  • 13 John JF Jr, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis 1997;24:471-85.
  • 14 Ratilal B, Costa J, Sampaio C. Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts. Cochrane Database Syst Rev 2006;3:CD005365.
  • 15 ECDC/EMEA Joint Technical Report. The bacterial challenge: Time to react. European Centre for Disease Prevention and Control, Stockholm; 2009. Available from: http://www.ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf. [last accessed on 2011 Mar 28].
  • 16 Kollef MH, Micek ST. Strategies to prevent antimicrobial resistance in the intensive care unit. Crit Care Med 2003;33:1845-53.